Skip to main content

GOLDMAN SACHS GROUP INC

Position in VYGR — Voyager Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in VYGR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,650,524
+$459,213 QoQ
Shares Held
427,597
+41.1% QoQ
Ownership
0.708%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VYGR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. VYGR ranks #233 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VYGR

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,650,524 427,597
2025-12-31 $1,191,311 303,133
2025-09-30 $1,389,665 297,573
2025-06-30 $873,648 280,916
2025-03-31 $755,006 223,375
2024-12-31 $1,651,398 291,252
2024-09-30 $1,920,706 328,326
2024-06-30 $3,511,913 443,984
2024-03-31 $3,553,710 381,709
2023-12-31 $1,519,410 180,025
2023-09-30 $1,093,672 141,119
2023-06-30 $943,697 82,419
2023-03-31 $1,342,388 174,110
2022-12-31 $425,450 69,746
2022-09-30 $511,215 86,354
2022-06-30 $649,159 109,841
2022-03-31 $865,326 113,560
2021-12-31 $90,196 33,283
2021-09-30 $147,140 55,947
2021-06-30 $719,399 174,189
2021-03-31 $254,103 53,950
2020-12-31 $2,027,588 283,579
2020-09-30 $2,214,067 207,504
2020-06-30 $4,613,291 365,554
2020-03-31 $3,844,134 420,124